See more : Marinus Pharmaceuticals, Inc. (MRNS) Income Statement Analysis – Financial Results
Complete financial analysis of Australian Gold and Copper Limited (AGC.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Australian Gold and Copper Limited, a leading company in the Gold industry within the Basic Materials sector.
- Lennar Corporation (0JU0.L) Income Statement Analysis – Financial Results
- Allied Biotech Corporation (1780.TWO) Income Statement Analysis – Financial Results
- Canadian Western Bank (CWESF) Income Statement Analysis – Financial Results
- Technocraft Industries (India) Limited (TIIL.BO) Income Statement Analysis – Financial Results
- YTO Express Group Co.,Ltd. (600233.SS) Income Statement Analysis – Financial Results
Australian Gold and Copper Limited (AGC.AX)
About Australian Gold and Copper Limited
Australian Gold and Copper Limited, an exploration company, explores for and develops multi-asset gold portfolio in Australia. The company primarily focuses on the exploration of gold, copper, and base metals. It holds a 100% interest in the Moorefield project that comprise two granted exploration licenses covering an area of 481.5 square kilometers; Gundagai project, which consists of an exploration license covering an area of 265 square kilometers; and Cargelligo project that include an exploration license covering an area of 227 square kilometers located in Lachlan Fold Belt in New South Wales. The company was incorporated in 2019 and is headquartered in Nedlands, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 25.97K | 25.64K | 24.14K | 5.49K | 0.00 | 0.00 |
| Gross Profit | -25.97K | -25.64K | -24.14K | -5.49K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 518.24K | 277.77K | 1.50M | 3.50K | 42.00K |
| Selling & Marketing | 0.00 | 483.86K | 0.00 | 0.00 | 0.00 | -38.50K |
| SG&A | 912.42K | 1.00M | 277.77K | 1.50M | 3.50K | 3.50K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 912.42K | 1.00M | 625.89K | 2.02M | 3.50K | 3.50K |
| Cost & Expenses | 938.38K | 1.03M | 625.89K | 2.02M | 3.50K | 3.50K |
| Interest Income | 293.97K | 95.28K | 46.72K | 3.42K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 25.97K | 25.64K | 24.14K | 5.49K | 3.50K | 42.00K |
| EBITDA | -618.45K | -1.63M | -555.03K | -2.01M | -3.50K | -3.50K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -938.38K | -1.03M | -625.89K | -2.02M | -3.50K | -3.50K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 293.97K | -628.77K | 1.98K | 3.42K | 0.00 | 0.00 |
| Income Before Tax | -644.41K | -1.66M | -579.17K | -2.01M | -3.50K | -3.50K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 293.97K | 2.00 | -204.35K | -231.07K | -3.50K | -42.00K |
| Net Income | -644.41K | -1.66M | -579.17K | -2.01M | -3.50K | -3.50K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | -0.02 | -0.01 | -0.02 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.02 | -0.01 | -0.02 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 165.17M | 100.00M | 100.00M | 100.00M | 115.00M | 115.00M |
| Weighted Avg Shares Out (Dil) | 165.17M | 100.00M | 100.00M | 100.00M | 115.00M | 115.00M |
Source: https://incomestatements.info
Category: Stock Reports